Claas Kirchhelle
banner
kirchhelle.bsky.social
Claas Kirchhelle
@kirchhelle.bsky.social
Historian of bugs & drugs: interested in #microbes #antibiotics #vaccines #phages; author of: Pyrrhic Progress (2020), Bearing Witness (2021), Typhoid (2022), Fear & Fever (2024) - Associate Professor INSERM (CERMES3, Paris): https://www.bugsdrugs.org/
Would love to know more about this research project!
November 24, 2025 at 8:58 AM
While current intervention models will undoubtely yield novel compounds, diversifying R&D systems, investing in underlying infrastructure, and building capacity beyond high-income countries is key to ensuring a more sustainable alignment of innovation & access (9/9).
November 21, 2025 at 2:37 PM
Ultimately, there is a limit to what societies can afford to pay for the perpetual renewal of the antibiotic infrastructures that underpin modern and food production systems – meanwhile, alternative innovation models exist... (8/9)
November 21, 2025 at 2:37 PM
Drawing on sociological research on assetization & assessing rising estimates for required push/pull incentives, we argue that trying to keep up with open-ended revenue expectations is not a sustainable public health strategy. (7/9)
November 21, 2025 at 2:37 PM
Focusing on companies themselves - and particularly the SMEs who start to dominate the innovation ecosystem from ca. 2000 onwards -, the article, however, also shows that public incentives have struggled to keep up with surging profit expectations by investors and financial markets (6/9)
November 21, 2025 at 2:37 PM
This narrative originated in & fell on fertile ground within high-income countries where governments began to advocate in part competing financial models from ca. 2010. The article covers proposed push & pull incentives including the creation of new PPPs, PDPs, and subscription models (5/9)
November 21, 2025 at 2:37 PM
Key to the Empty Pipeline metaphor's success was its ability to present antibiotic innovation (& with it #AMR) as a market problem that could be fixed via fiscal & regulatory interventions. (4/9)
November 21, 2025 at 2:37 PM
This was despite the fact that antibiotics were still generating profits, major companies were actively defending patents & most clinicians considered stewardship & access rather than innovation a priority. (3/9)
November 21, 2025 at 2:37 PM
We use archival research, discourse evaluation, and financial evaluation to show how a new technological deficit imaginary - The Empty Pipeline – gradually captured political, scientific, and economic imaginaries in high-income countries from the mid-1990s onwards. (2/9)
November 21, 2025 at 2:37 PM